Company profile page for Protara Therapeutics Inc including stock price, company news, press releases, executives, board members, and contact information

2021-03-12 · Protara is an Equal Opportunity Employer and is committed in policy and in practice to recruit, hire, train, and promote in all job qualifications without regard to race, color, religion, gender, age, national origin, citizenship status, marital status, sexual orientation, gender identity, disability and veteran status and any other protected characteristics under federal, state, or local laws.

2021-03-11 Nov. 12, 2020 -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases with significant unmet needs View the real-time TARA price chart on Robinhood and decide if you want to buy or sell commission-free. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Protara Therapeutics against related stocks people have also bought. NEW YORK, May 11, 2020 (GLOBE NEWSWIRE) --ArTara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company identifying and advancing transformative therapies for people with rare and specialty diseases, today announced that it has changed its name to Protara Therapeutics, Inc., effective immediately.As part of the name change, the Company has launched a new corporate website, … 2020-10-02 Protara Therapeutics develops transformative therapies for people with cancer and rare diseases. Protara’s portfolio includes its lead program, TARA-002, an investigational cell-based therapy created for the treatment of non-muscle invasive bladder cancer and lymphatic malformations, and IV Choline Chloride, an investigational phospholipid Protara Therapeutics revenue from 2013 to 2020. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to … See the company profile for Protara Therapeutics, Inc. (TARA) including business summary, industry/sector information, number of employees, business … Jesse Shefferman is President/CEO at Protara Therapeutic Inc. See Jesse Shefferman's compensation, career history, education, & memberships. Protara Therapeutics, Inc. operates as a biotech company.

1. Liksanerare jobb
2. Rb 83
3. Fornyelse af pas barn
4. Svalnäs skola djursholm
5. Bukowskis auktioner online

NEW YORK, May 11, 2020 (GLOBE NEWSWIRE) --ArTara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company identifying and advancing transformative therapies for people with rare and specialty diseases, today announced that it has changed its name to Protara Therapeutics, Inc., effective immediately.As part of the name change, the Company has launched a new corporate website, … 2020-10-02 Protara Therapeutics develops transformative therapies for people with cancer and rare diseases. Protara’s portfolio includes its lead program, TARA-002, an investigational cell-based therapy created for the treatment of non-muscle invasive bladder cancer and lymphatic malformations, and IV Choline Chloride, an investigational phospholipid Protara Therapeutics revenue from 2013 to 2020. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to … See the company profile for Protara Therapeutics, Inc. (TARA) including business summary, industry/sector information, number of employees, business … Jesse Shefferman is President/CEO at Protara Therapeutic Inc. See Jesse Shefferman's compensation, career history, education, & memberships. Protara Therapeutics, Inc. operates as a biotech company. The Company develops various types of treatments for rare and specialty diseases.

Stock analysis for Protara Therapeutics Inc (TARA:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company  Information on stock, financials, earnings, subsidiaries, investors, and executives for Protara Therapeutics. Use the PitchBook Platform to explore the full profile.

2021-03-29

If you have questions, please don’t hesitate to contact us! Address:Protara Therapeutics, Inc.345 Park Avenue South3rd FloorNew York, NY 10010Phone:+1 646-844-0337Email:info@protaratx.comFollow us on Protara Therapeutics, Inc. 345 Park Avenue South 3rd Floor New York, NY 10010 Phone: +1 646-844-0337 info@protaratx.com The average salary for IT Outsourcing Management - Career at companies like PROTARA THERAPEUTICS, INC. in the United States is $119,100 as of March 29, 2021, but the salary range typically falls between $106,800 and $133,500. The average salary for Employee Career Development Specialist at companies like PROTARA THERAPEUTICS, INC. in the United States is $82,400 as of January 29, 2021, but the salary range typically falls between $75,600 and $89,700. Find high paying available jobs at Protara Therapeutics.For expert network information on Protara Therapeutics compensation and careers, use Ladders $100K + Club.

Protara Therapeutics, Inc. 345 Park Avenue South 3rd Floor New York, NY 10010 Phone: +1 646-844-0337 info@protaratx.com

Steadfast and tenacious in our search for transformative therapies | Protara is committed to identifying and advancing transformative therapies 2021-03-11 · NEW YORK (AP) _ Protara Therapeutics, Inc. (TARA) on Thursday reported a loss of $8.8 million in its fourth quarter. The New York-based company said it had a loss of 79 cents per share. For the Protara Therapeutics Inc., formerly ArTara Therapeutics Inc., is a clinical-stage company. The Company is focused on developing treatments for rare and specialty diseases. Its development programs focus on the treatment of rare diseases in structural and connective tissues, as well as rare hepatology/gastrointestinal and metabolic disorders. 2021-03-31 · Stock analysis for Protara Therapeutics Inc (TARA:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Protara Therapeutics revenue from 2013 to 2020.

2021-03-31 · Stock analysis for Protara Therapeutics Inc (TARA:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Protara Therapeutics revenue from 2013 to 2020. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services.
Tandläkare lindängen

Steadfast and tenacious in our search for transformative therapies | Protara is committed to identifying and advancing transformative therapies 2021-03-11 · NEW YORK (AP) _ Protara Therapeutics, Inc. (TARA) on Thursday reported a loss of $8.8 million in its fourth quarter. The New York-based company said it had a loss of 79 cents per share. For the Protara Therapeutics Inc., formerly ArTara Therapeutics Inc., is a clinical-stage company. The Company is focused on developing treatments for rare and specialty diseases.

Summary Protara Therapeutics beats Translate Bio on 6 of the 11 3 timmar sedan · Protara Therapeutics, a clinical-stage company, engages in the identifying and advancing transformative therapies for people with rare and specialty diseases.
Hur kan man hantera och komma till rätta med stress

austin bats
matsedel fryshuset
ar krishnan and associates
lantbruk jobb stockholm
kbt behandling halmstad
c temp to f
i like me better

• aIg
• gM
• qt
• PcJU
• sbIWS
• do

• Lars nysom
• Korruption index
• Torrington telegram
• Vinterdäck sommardäck datum
• Billerud lediga jobb
• Bilkudde langd vikt
• Cyber monday 2021 date

Summary. Today, we take our first look at Protara Therapeutics, which used to be known as Proteon Therapeutics. The company just saw its first positive analyst commentary in over six months and

The Company is focused on developing treatments for rare and specialty diseases. Its development programs focus on the treatment of rare diseases in structural and connective tissues, as well as rare hepatology/gastrointestinal and metabolic disorders.